PPAG RSS Feed

Early Bird Registration Deadline (Specialty Conference)

Thu, 25 Mar 2010 13:30:00 GMT

Early Bird Registration Deadline (Specialty Conference)
Start Date: 25-Mar-10 8:30 AM
End Time: 25-Mar-10 11:30 PM

Hotel Reservation Deadline (Specialty Conference)

Wed, 31 Mar 2010 13:30:00 GMT

Hotel Reservation Deadline (Specialty Conference)
Start Date: 31-Mar-10 8:30 AM
End Time: 31-Mar-10 5:30 PM

Board of Directors Meeting

Fri, 16 Apr 2010 13:00:00 GMT

Board of Directors Meeting
Start Date: 16-Apr-10 7:00 AM
End Time: 16-Apr-10 12:00 PM
Location: Salt Lake City Marriott Downtown

Salt Lake City Marriott Downtown

Pediatric Chronic Disease Specialty Conference

Fri, 16 Apr 2010 19:00:00 GMT

Pediatric Chronic Disease Specialty Conference
Start Date: 16-Apr-10 1:00 PM
End Time: 18-Apr-10 12:30 PM
Location: Salt Lake City Marriott Downtown, Salt Lake City, UT 84101
Speaker: Stephen R. Covey

Event Details:

The Pediatric Chronic Disease Specialty Conference will offer continuing education sessions on the medication management of seizure disorders, dermatology, transplant, sickle cell, pain, HIV, and mental health issues. A full educational agenda is forthcoming.

For the full conference agenda, travel information, and continuing education information please visit the Conference website at www.ppag.org/sc10.

Salt Lake City Marriott Downtown

75 South West Temple

Salt Lake City, UT US 84101

FPPAG Application Deadline

Tue, 01 Jun 2010 12:30:00 GMT

FPPAG Application Deadline
Start Date: 1-Jun-10 7:30 AM
End Time: 1-Jun-10 5:30 PM

Abstract Submission Deadline

Fri, 04 Jun 2010 13:30:00 GMT

Abstract Submission Deadline
Start Date: 4-Jun-10 8:30 AM
End Time: 4-Jun-10 5:30 PM

Early Bird Registration Deadline (Annual Conference)

Thu, 05 Aug 2010 13:30:00 GMT

Early Bird Registration Deadline (Annual Conference)
Start Date: 5-Aug-10 8:30 AM
End Time: 5-Aug-10 5:30 PM

Neonatal-Resident Small Grant Application Deadline

Wed, 15 Sep 2010 13:30:00 GMT

Neonatal-Resident Small Grant Application Deadline
Start Date: 15-Sep-10 8:30 AM
End Time: 15-Sep-10 5:30 PM

19th Annual Pediatric Pharmacy Conference and Annual Meeting

Thu, 07 Oct 2010 17:00:00 GMT

19th Annual Pediatric Pharmacy Conference and Annual Meeting
Start Date: 7-Oct-10 12:00 PM
End Time: 10-Oct-10 12:00 PM
Location: St. Charles Convention Center/Embassy Suites, Saint Charles, MO 63301-2855
Event Details:

Historic St. Charles, Missouri will host the 19th Annual Pediatric Pharmacy Conference and PPAG Annual Meeting. St. Charles is located in the heart of the Midwest. It is only 20 minutes from downtown St. Louis and only 10 minutes from the St. Louis Lambert International Airport. St. Charles is known for its Historic District which houses over 125 specialty and antique shops along with the 25 quaint restraurants and attractions that line the Missouri River. In St. Charles, you'll walk in the footsteps of Lewis and Clark and exprience part of America's history.

PPAG has secured a special room rate of $139.00 per night at the Embassy Suites St. Louis-St. Charles Hotel and Spa. Reservations can be made by calling the Hotel directly at 636-946-6644 or Embassy Suites Brand Reservations at 1-800-EMBASSY. Conference participants must identify themselves as being with the Pediatric Pharmacy Advocacy Group at the time the reservation is made in order to receive the group rate.

Reservations must be made on or before September 5, 2010 at 12:00 midnight (central time) to receive the discounted rate. After the cut-off date, reservations will be subject to availability and room-rate increases. PPAG cannot guarantee any reservations after September 5, 2010.

St. Charles Convention Center/Embassy Suites

230 South Main Street

Saint Charles, MO USA 63301-2855

Seeking Volunteers: Nominations Committee

Matthew Helms — Thu, 18 Mar 2010 16:00:00 GMT

PPAG is currently seeking two (2) volunteers to join the 2010 Nominations Committee. This is an ad-hoc appointment. The length of the appointment will last through the nominations process, which will end this summer. You must be an active member of PPAG to be considered for appointment.

The Nominations Committee consists of the current Chair of the Board, the Immediate-Past Chair, the Vice President of Finance, and two (2) active members of PPAG. The Executive Director serves as an ex-officio member of the committee.

This year, the committee will review nominations for the following positions:

1. President-elect

2. Treasurer

3. At-Large member of the Board

4. At-Large member of the Board

If you are interested in serving in this capacity, please send an electronic letter of interest to Matt Helms, PPAG Executive Director, at matthew.helms@ppag.org on or before April 2, 2010.

Candidates for the Nominations Committee appointment will be reviewed and selected by the full Board of Directors.

18-Mar-10 11:00 AM

Call for Abstracts

Matthew Helms — Thu, 18 Mar 2010 16:00:00 GMT

Deadline June 4, 2010

Submit Abstract Here

General Information

All practitioners/investigators in the field of pediatric clinical pharmacy, whether members of PPAG or not, are invited to submit abstracts of papers to be considered for platform or poster presentation at the 19th PPAG Annual Meeting, October 7-10, 2010 at the St. Charles Convention Center in St. Charles, MO.

All research and practice abstracts should be no longer than 450 words. Research abstracts will be published in the Journal of Pediatric Pharmacology and Therapeutics. Platform Presentations and Best Practice Awards will be chosen from the abstracts submitted.

There are two tracks for abstract submissions:

Research/Scientific Track
Practice Based Track

Research/Scientific Track

Research abstracts presented at PPAG report the results of a scientific investigation or a clinical observation (case report) involving some aspect of pharmacotherapy. Scientific investigations can be either clinical, basic, or translational and are either hypothesis-driven or descriptive in nature. To be accepted for presentation, research abstracts must have either preliminary or final results. The abstract may be submitted in any of the following categories: Scientific, Case Report, and Encore Presentations (a poster that has been presented and published elsewhere. The original citation must accompany encore presentations).

Students, Residents and Fellows whose research projects are ongoing at the time of submission but do not have preliminary results are encouraged to submit in the Research-in-Progress category. Abstracts accepted in this category will not be published in the Journal of Pediatric Pharmacy and Therapeutics. However, if such projects do have preliminary or final results, they should be submitted in Original Research, or Encore Presentation category. For useful tips in drafting your abstract, please visit: Guidelines for Abstract Preparation.

All submissions, except those in Research-in Progress and encore categories, will be eligible for the Young Investigator or Best Original Paper award. The finalists will be judged by a panel of judges during the poster and platform presentation sessions.

The Pediatric Pharmacy Advocacy Group gives two Research Awards based on abstract submissions each year. Primary authors may be considered for all awards for which they are eligible, but may win only one award.

There are two Reasearch Award categories for eligible authors.

Outstanding Original Paper

Outstanding Original Paper Investigators will be evaluated on the basis of their written abstract and the quality of their presentation at the Meeting. The winner will receive complimentary registration to next year's Annual Meeting and a framed certificate.

PPAG Young Investigator Award

PPAG Young Investigator Award is available to investigators who have been in practive five (5) years or less . This award will be granted to the investigator based on their written abstract and the quality of their presentation at the Meeting.

Submit Abstract Here

Best Practice Track

Best and Innovative Pediatric Pharmacy Practice Abstracts typically describe programs, systems, or projects that are innovative, creative, cost-effective, and improve practice in pediatric pharmacy. BPA/IPPP Posters will be selected based on achievement of excellence in each of the four areas.

Winners of the Best Practice Award will be chosen from accepted abstracts. The program, system, or project can be an individual or collaborative effort in any type of practice setting, including academia, institutional, or ambulatory care. Unlike Research Abstracts, Best Practice Abstracts are not required to have final or preliminary data, but should include sufficient details about the rationale, process, and hypothesis of the impact should the program, system, or project be implemented. Accepted abstracts will be published in the Journal of Pediatric Pharmacology and Therapeutics.

Submissions should include any pictures, graphs, figures and data tables that supports the summary. Each of these must be clearly labeled and described.

Lexi-Comp Best Practice Awards

PPAG will award two (2) Best Practice Awards during the 18th Annual Meeting in Cleveland, Ohio. The awards are given to innovative and creative pharmacy programs that advance the mission, vision, and goals of the organization. Recipients of the award receive a plaque for the practice site and a certificate recognizing each contributor to the program. Award recipients will share their best practice during a presentation at the Annual Meeting and as a poster at the Annual Meeting.

The Best Practice Awards are generously supported by Lexi-Comp.

Deadline June 4, 2010

Submit Abstract Here

18-Mar-10 11:00 AM

EPIC CPOE Teleconference

David Prococcini — Wed, 17 Mar 2010 21:00:00 GMT

One January 28, 2010, PPAG hosted a teleconference conducted by West Virginia University Hospitals. The teleconference was moderated by David Prococcini, PharmD, a PGY-1 Resident at West Virginia. Below is a summary of the presentation and discussion that followed.

The pediatric pharmacy team at West Virginia University Hospitals collaborated to identify and discuss the major issues with the EPIC system experienced at the institution; these were issues that pertain mainly to the pediatric pharmacy as opposed to the rest of the institution. EPIC has become a more popular and advanced CPOE system across the United States, so it was most beneficial to bring these issues to the attention of other pediatric institutions. By having a teleconference and webinar, the institutions who utilize the EPIC system would have an opportunity to collaborate and discuss possible methods to overcome some of these barriers.

After gathering, the pediatric pharmacy team from WVUH separated the issues into six categories:

Order Entry
Dispense
Dosing
Timing & Charting
Total Parenteral Nutrition
Chemotherapy

Screen shots were then gathered and formulated within a PowerPoint® presentation for the webinar. The objectives of the presentation were as follows:

Review the most common challenges of utilizing EPIC CPOE for pediatric pharmacy members
Discuss methods to overcome common discrepancies of EPIC CPOE
Exchange ideas and advice for those currently in the EPIC build process

1. Order Entry

When ordering a medication within EPIC a patient’s age, weight, location, selection of product, and concentration of the product all need to be witnessed to select the correct order. This can be confusing and tedious as there are multiple options for a medication (i.e. Fentanyl 4 mcg/mL, 10 mcg/mL, 50 mcg/mL, bolus & drip, etc.). There are also different order pathways including:

Preference List: Most common medication available and ordered frequently; includes all medications on formulary
Facility Preference List: Less common medications available; includes medications on formulary
Database Lookup: Includes medications not on formulary or medications that may need to be ordered

With multiple lists and options available for medications, it becomes difficult and tedious to know where and what to select. This may increase the risk of error due to the multiple concentrations of medications available.

2. Dispense

Both “Dispense Code” and “Dispense Locations” upon verification of an order dictates the type of label printed, and where it is printed to. The “Dispense Code” may ne “IV Piggy Back,” “IV Syringe,” “Oral Syringe,” etc. which will dictate the type of lavel printed. This becomes a challenge, especially in de-centralized pharmacies, and the pharmacist needs to pay close attention to assure the appropriate label is printed.

3. Dose

The biggest challenge in regards to dose is verifying whether an order was done so via “mg/kg (mg/kg/dose)” or “mg/kg/day.” Epic will divide out the dose depending on the frequency if a frequency is not chosen it will give the total dose.

Another issue is in regards to maximum dose. If a medication is ordered via “mg/kg (mg/kg/dose)” and a maximum dose is surpassed, EPIC may not notify the pharmacist. This becomes troublesome especially in regards to overweight/obese patients.

Example:

100 kg patient ordered Cefepime 50 mg/kg Q 8h

= 5 g Q 8h [Max Adult Dose = 2 g Q 8h]

Example:

Patient has orders for acetaminophen 15 mg/kg Q 4-6 prn AND acetaminophen/codeine Q 6 prn

- System will not flag when max of 75 mg/kg/day of acetaminophen has been reached

Another dosing issue pertains to gestational age when ordering medications for neonates. EPIC only accounts for Postmenstrual Age (PMA), per NeoFax® in regards to dosing for patients up to 30 postnatal days. After a patient’s age is beyond 30 days, the system will calculate dosing based on Lexi-Comp® dosing ranges. Pharmacist may need to refer to NeoFax® prior to initiating therapy. A system that accounts for PMA during the EPIC build should be utilized.

Example:

Patient MP:

PMA – 28 Weeks

Postnatal Days – 1 Day

Gentamicin Dose

– Per NeoFax®: 4 mg/kg Q 24h
– Per Lexi-Comp®: 5 – 7.5 mg /kg Q 24h

Automatic rounding of doses/volumes is sometimes an issue faced by ordering and verifying providers. The system may round medications to an immeasurable quantity (i.e., 0.05 mL) depending on which product and concentration is selected (i.e., morphine 2 mg/mL vs. morphine 10 mg/mL). An example of this may be seen in the EPIC PowerPoint® presentation.

4. Timing and Charting

Timing of medications can be confusing and troublesome especially when an order is modified or re-ordered. The reason for this is modified orders default start time is set for the next hour. This means that the ordering user needs to pay attention to when the last dose was given and change the start time.

Example:

Furosemide 5 mg IV q6 they change it to 5 mg IV q12 if the patient received the last dose at 1000 and it is now 1100 the dose will be scheduled for 1200.

- The patient does not need a dose till 2200

The charting of medications to be administered on the electronic MAR should also be reviewed by the pharmacist upon and after verification, because future due times of ordered medications are automatically charted on patient’s MAR report. Times ACTUALLY administered are usually different than time predicted. The pharmacist needs to consider this with all medications especially medications that require serum-level monitoring (i.e., aminoglycosides, digoxin, etc.) and medications with maximum daily doses (i.e., acetaminophen, ketorolac, etc.). This process also reflects the ordering of drug levels for medications that require serum monitoring, as the times that the levels need to be drawn can change and be confusing for the nursing staff.

5. Total Parenteral Nutrition

In regards to TPN, the most challenging aspect may be ordering the correct type. At WVUH the selections vary based mainly on age.

Fortunately, the EPIC system gives the option of choosing a peripherally vs. centrally infused TPN. Depending on which type of line placement the patient has and the type of order selected, the system will flag the ordering provider if maximum mOsm/L is exceeded (≥ 900 mOsm/L). The addition of heparin is an option for both peripheral and central TPN orders as well.

The system will also calculate the calcium: phosphorous ratio and if exceeded, will show the pharmacist the calculation utilized to determine the likely precipitation of the product. The EPIC system also accounts for addition of cysteine (40:1) and the amount of lipids in TPN when calculating the likelihood of precipitation.

After ordering, the outline of each TPN for the previous 5 days will appear on the main, patient summary page of a patient’s profile. A screenshot of this can be seen in the EPIC PowerPoint®.

6. Chemotherapy

A separate system is utilized for order entry and charting of chemotherapy orders. With this system, the ordering provider or pharmacist is able to enter entire chemotherapy regimens either manually, or with order sets in conjunction with ECOG protocols. One of the major benefits of the order sets is that if ordered by a physician, the correct product/dilution is assured to be chosen.

After ordering the regimens in the chemotherapy system, the orders need to be signed and released into the EPIC system. In order to do this, the protocol is first entered in the treatment plan manager/springboard report. The medications then need to be reviewed and signed by physician. The physician will usually call pharmacist after the orders have been signed. The pharmacist will then release orders into EPIC system to be verified like a standard EPIC-order.

In regards to the dosing of chemotherapeutics, everything is build based on mg/kg or mg/m2. This means that if a patient’s weight/BSA is entered wrong the entire order will be incorrect. The major downfall of this is that the incorrect height and weight will remain in the system. However, if a new value is entered, doses will be calculated based on new weight. The system accounts for ≥ 10% difference from previous height and weight before the order is “flagged.” Once flagged, the order has to be reviewed and then over-ridden for the CA/nurse that enters the order.

Words of Wisdom for the EPIC build process:

Make sure trainers, builders, validators, and pharmacists are on-site during go-live
Assure that pharmacists present are PEDS SPECIALTY TRAINED
Extra staff members NEED to be present during go-live
Be ready for chaos
Be ready if system fails

Any questions may be referred to the following members who lead the EPIC Teleconference for the Pediatric Pharmacy Advocacy Group:

David Prococcini, PharmD, PGY-1 Resident. procaccinid@wvuh.com

Justin Hare, PharmD- Pharmacy Manager harej@wvuh.com

Kelsey Briggs, Pharm.D. – Pediatric ICU briggsk@wvuh.com

Jennifer Shahan, Pharm.D. – Neonatal ICU shahanj@wvuh.com

Lisa Biondo, Pharm.D. – Pediatric Heme/Onc biondol@wvuh.com

PPAG would like to express our sincere appreciation to the team at West Virginia University Hospitals for conducting the teleconference.

17-Mar-10 4:00 PM

Spotlight on Membership Committee

Bernard Lee — Mon, 15 Mar 2010 18:00:00 GMT

CONNECTING MEMBERS... BUILDING COMMUNITY...

The Membership Committee is looking forward to another successful year as it continues to focus on goals set by the board. After 2 years as the committee chair, Keith DelMonte of Rochester, NY has handed the baton to Bernie Lee of Rochester, MN. Bernie has been a vital part of the committee for several years and was one of the first recipients of the PPAG Spirit Award that started in 2008.

For the past few years the committee has published the Pediatric Pharmacy Advocate, the official newsletter of PPAG. The Advocate is packed with information, including overviews of real hot topics being discussed on PediNet listserves! Having a quarterly newsletter is not always timely with many topics, so the Committee's approach has changed for the year. You will now receive an electronic and interactive monthly Newsletter. The newsletter will contain a Calendar of Events, articles linked back to the PPAG website, job listings, a list of new members, and so on.

The committee continues to provide member feedback to the home office to expand the website in order to bring added benefits to our members. One of the main committee goals in 2009 was to expand the residency database. 18 months ago PPAG had around 25 programs listed on the directory. Today, we have 49! In 2010, the committee will continue to encourage residency directors update their material.

PPAG knows that it is the little things that matter. Committee members will be browsing the website looking for broken links and errors to make your website surfing as problem free as possible.

Lastly, the membership committee is reaching out to remind people during the grace period that it is time to renew with a friendly telephone call or email. This approach is progressing well as our renewal percentage is up! Our members are important and your membership is important to PPAG.

15-Mar-10 1:00 PM

PPAG Recognizes Local Network

Matthew Helms — Thu, 18 Feb 2010 18:00:00 GMT

PPAG is pleased to announce that the Cleveland-Akron Area Pediatric Pharmacists (CAAPP) has been officially recognized by as a Local Community and Network (LCN).

The purpose of the Cleveland Akron Area Pediatric Pharmacists (CAAPP) is to support local pediatric practitioners by providing an avenue to exchange ideas and practices and provide additional educational opportunities for Continuing Pharmacy Education. CAAPP offers networking opportunities, idea swaps, Journal Club sessions, social events, and volunteer opportunities. The geographical scope of CAAPP includes the Greater Cleveland and Akron/Canton area. JoEllen Hanigosky, PharmD, Clinical Coordinator at Akron's Childre's Hospital, is the Chair of CAAPP.

"We are excited to recognize CAAPP as an official PPAG Local Network," said Michael Christensen, PharmD, Chair of the PPAG Board of Directors. "The Local Network recognition program allows us to acknowledge what our members are doing locally and connects PPAG with those efforts."

The Local Communities and Networks of the Pediatric Pharmacy Advocacy Group help make strong peer-to-peer connections that can make a real different in your career and practice.

Through networking events, local programming, regional news and volunteer opportunities, the Local Networks build a community of peers, advance careers and offer volunteer opportunities within the pediatric pharmacy community.

For more information about the Local Communities and Network (LCN) Recognition Program, click here.

18-Feb-10 12:00 PM

Be a Member Reporter: Submit Your Stories

Matthew Helms — Thu, 18 Feb 2010 14:00:00 GMT

Become a reporter for PPAG! We need to know what you know!

PPAG encourages all members to submit news and stories for the organization's newsletter and website.

Do you have a new job? Have you recently become Board Certified? Is your hospital or institution doing something new or unique? Has a colleague received an award? Do you need to promote something interesting? Let us know! Your stories will appear in the newsletter and/or website.

To sumit your news online, click here.

18-Feb-10 8:00 AM

Member of the Month: Catherine Tom-Revzon, BS, PharmD

Matthew Helms — Mon, 08 Feb 2010 22:00:00 GMT

Catherine Tom-Revzon, BS, PharmD

Catherine Tom-Revzon, BS, PharmD is a former associate professor of pharmacy practice at the Arnold & Marie Schwartz College of Pharmacy and Health Sciences at Long Island University. Her practice site was at the Children's Hospital at Montefiore as a clinical pharmacy manager in pediatrics. She was also adjunct assistant clinical instructor at the Columbia School of Nursing.

Catherine has published manuscripts in such journals as Pediatrics, the Journal of Perinatal and Neonatal Nursing, Clinical Therapeutics, and US Pharmacist.

She advocates for awareness of pediatric pharmacy through interviews with the mass media, such as The New York Times, Parents magazine, NPR, The Today Show, and Reader's Digest.

Catherine is coordinating PPAG's KidsMeds website (www.kidsmeds.info). Catherine and other members of PPAG's Advocacy Committee publish useful medication and health information and tips for parents. Catherine has served PPAG is various capacities throughout the years. She has most recently served as VP of Advocacy.

Catherine also blogs about children's health issues and parenting at http://www.babiesrx.blogspot.com/.

Because of her dedication to PPAG and parent education, we decided to "sit down" with Catherine and ask a few questions.

PPAG: Tell us about your blog, BabiesRx.

CT-R: As a clinical pharmacist, I offered medication education to families. It was such a well-received service that requests were later incorporated into the hospital's CPOE system as a "pharmacy consult." In addition to requests for discharge counseling, there were also times when we would be asked to dispel myths about using opioids, vaccines, stimulants, inhaled steroids, etc. I became a patient advocate and I enjoyed that part of my job tremendously. So when I decided to take time off from working, I needed a medium that would allow me to continue educating the public about the role of pharmacists and keeping parents abreast of current issues related to pediatric medication. The answer was starting a blog. BabiesRx, www.babiesrx.blogspot.com, serves to blend my knowledge and experiences as a pediatric pharmacist, an educator, and a parent. I post my views about relevant topics that pertain to the care of not only babies but older children and adolescents, too. Interesting discoveries are shared with fellow health care practitioners. And I alert caregivers about recalls of medications or side effects to be aware about. I subscribe to multiple listservs generated by the CDC, NIH, FDA, AAP, and other reputable sites, including online newspapers, so I get my topics from them. I also read blogs by fellow pharmacists and other health care professionals to get information. Believe it or not, Twitter is another great source. Personal accounts are also included in my blog as they occur in my life as a mom. It is also a fun blog where I find videos to educate children about topics like the flu.

PPAG: As a mom, do you practice what you preach as a "pharmacist blogger?"
CT-R: I do 99.9% of the time. We’ve occasionally missed doses of medicine.

PPAG: Speaking of social media, what role do you see this playing in the efforts here at PPAG?

CT-R: Social media has an incredible role for PPAG and KidsMeds. Outlets like Twitter, Facebook, and weblogs can help increase our visibility as an organization and enhance our ability to communicate and interact with a broader audience in a more timely manner. With over 700 members of PPAG, many of our members have not yet been able to match faces or voices to other fellow members, let alone share ideas with one another. Establishing groups and fan pages for PPAG and KidsMeds on Facebook has allowed more of our members to interact with PPAG and with colleagues who live in different time zones on a more regular basis. Twitter is not only a great resource for information, it is also a means for PPAG and KidsMeds to build relationships with other organizations who share our passion. While the internet is still how the majority of the PPAG and KidsMeds members access our websites, many of them are using their phones to look up information on the web and disseminate breaking news to their colleagues and friends via email. It's amazing how powerful these gadgets are! In fact, one can access and post Facebook and Twitter entries using these gadgets. Blog posts to raise awareness of pertinent issues can also be made in a matter of minutes. Furthermore, our reputation as the primary source for effective drug therapy in children can be further developed with the use of social media. [Editors Note: Follow PPAG on Twitter at www.twitter.com/theREALppag and KidsMeds at www.twitter.com/KidsMeds.]

PPAG: You are clearly passionate about being a pediatric pharmacist. Why did you choose pediatric pharmacy in the first place?
CT-R: Growing up I found that I connect with children easily. Given that gift and my thirst for challenges, I decided to specialize in pediatric pharmacy. I wanted to help treat children and provide education. I also really like compounding different dosage forms.

PPAG: What do you find most unique about pediatric patients as compared to adult patients?
CT-R: If they are able to express themselves, pediatric patients are more honest about whether something works or not. If the analgesic is not working, you’ll know. Whereas, an adult may want to hide how they really feel because of cultural differences. It’s also more challenging when interacting with children. You really need to get down to their level, engage them with their favorite cartoon characters, and gain their trust before you can start teaching them about their medications.

PPAG: Describe your most significant accomplishment as a pediatric pharmacist.

CT-R: When I first started at the Children's Hospital at Montefiore as a clinical pharmacy manager, I volunteered to help organize the education table for the Pharmacy Department when the Children's Health Fair was reinstated. In addition to educational pamphlets and giveaways, I wanted to leave an impression with the families we were going to encounter. So, I took the medicine vs. Candy poster that the Poison Control Center distributes and brought it to life. I sought colorful pills and matched them to candy look-alikes. Then I glued them on a large poster board and made it into an interactive game. It was such a hit that the CEO of the hospital wanted to see it grow into something bigger. The next few weeks I was meeting with the marketing, Public relations, and health education departments of the hospital to design a more permanent display and a brochure. Although the game board did not become a permanent display in the hospital, it was featured on the John Walsh Show and has been a popular piece for various health fairs, poison prevention events, and departmental functions. It has even traveled to different elementary schools to teach children that medicine is not candy. For this creation and other outreach efforts, I won Pharmacist of the Year and Clinical Practitioner of the Year from local pharmacy organizations and began to get more media requests through the PR department. I was happy to be able to tell the public about pediatric pharmacists and what we’re capable of doing in contributing to their care.

PPAG: Your passion clearly inspired others to take action. What advice would you offer pharmacy students and residents interested in pursuing a career in pediatrics?
CT-R: Let your dream and passion to become a pediatric pharmacist be known to everyone you interview with (advisors, mentors, residency coordinators). Even as a student, your clerkships can be selected to cultivate this interest. When you're looking for a pharmacy practice residency, find out if the program offers pediatric rotations/electives and flexibility; the residency can sometimes be tailored to suit your needs. Finally, don't give up. If you don't match with your dream residency or job the first time, find out what you can do to increase your chances next time and try again. [Editors note: Check out PPAG's Residency Directory: click here.]

PPAG: Why did you join PPAG?
CT-R: I joined PPAG as a resident, though my first interaction with PPAG was as a student at the ASHP Midyear meeting. I remember sitting at the CE program that PPAG was presenting and thinking, “Wow! I want to be a part of this group! I want to make a difference with others who also like pediatric pharmacy.” As a member, I wanted to learn everything I could about pediatric pharmacy and then contribute back to the organization.

PPAG: Now, for some fun questions. If you were a drug, which one would you be and why?
CT-R: I would be a vaccine, because the pieces of knowledge that I share with colleagues, caregivers, and patients provoke a reaction and a memory so that the next time a similar situation is encountered, they will know how to deal with it. There’s sometimes a shortage of me, too.

PPAG: Name one thing your colleagues might not know about you.
CT-R: I own over 500 books (mostly novels) that I haven't read, yet.

PPAG: Thanks, Catherine, for your time. It's been an enjoyable conversation.

CT-R: Thank you. It's been a pleasure.

Editors Note: Each month, PPAG will feature a member doing outstanding things in pediatric pharmacy practice and/or in the community. To nominate someone to be featured, please contact the PPAG office.

8-Feb-10 4:00 PM

Stephen Covey to Give Keynote Address at Specialty Conference

Matthew Helms — Sat, 23 Jan 2010 02:00:00 GMT

Stephen R. Covey, author of The 7 Habits of Highly Effective People will provide the Keynote Address at the Pediatric Chronic Disease Specialty Conference on April 16, 2010 in Salt Lake City, Utah.

In 1996, Stephen R. Covey was recognized as one of Time magazine's 25 most influential Americans and one of Sales and Marketing Management's top 25 power brokers.

Dr. Covey is the author of several acclaimed books, including the international bestseller, The 7 Habits of Highly Effective People. It has sold more than 15 million copies in 38 languages throughout the world. Other bestsellers authored by Dr. Covey include First Things First, Principle-Centered Leadership, with sales exceeding one million, and The 7 Habits of Highly Effective Families.

Dr. Covey's newest book, The 8th Habit: From Effectiveness to Greatness, which was released in November 2004, has risen to the top of several bestseller lists, including New York Times, Wall Street Journal, USA Today Money, Business Week, and Amazon.com and Barnes & Noble. The 8th Habit has sold more than 360,000 copies.

In 2002, Forbes named The 7 Habits of Highly Effective People one of the top 10 most influential management books ever.
A survey by Chief Executive Magazine recognized The 7 Habits of Highly Effective People as one of the two most influential business books of the twentieth century.
The 7 Habits of Highly Effective People audiobook on tape is the best-selling nonfiction audio in history, selling more than 1.5 million copies.
Over two million copies of First Things First have been sold. Simon & Schuster expressed the opinion, "...First Things First is the best-selling time management book ever."
Dr. Covey's book The 7 Habits of Highly Effective Families was released in October 1997 and ranked fourth on the New York Times list within three months of its release date. It is the No. 1 best-selling hardcover book on family.

Dr. Covey is cofounder and vice chairman of FranklinCovey, the leading global professional services firm with offices in 123 countries. FranklinCovey shares Dr. Covey's vision, discipline and passion to inspire, lift and provide tools for change and growth of individuals and organizations throughout the world.

Dr. Covey's organizational legacy to the world is Covey Leadership Center. On May 30, 1997, a merger of Covey Leadership Center with Franklin Quest created FranklinCovey. Dr. Covey's vision of empowering organizations to implement "principle-centered" leadership in their cultures continues to be an important focus of FranklinCovey.

For more information and to register for the Pediatric Chronic Disease Specialty Conference, please click here.

22-Jan-10 8:00 PM

Committee Spotlight: The Advocacy Committee

Matthew Helms — Thu, 07 Jan 2010 15:00:00 GMT

The Advocacy Committee, co-chaired by Kristin Klein, PharmD and Tara Smith, PharmD, accomplished many things in 2009 and is looking forward to a terrific 2010!

The flagship program of the Advocacy Committee is a website for parents called KidsMeds (www.kidsmeds.info). Coordinated by Catherine Tom, PharmD, the websites provides relevant and current information related to children's health. The wesbite continues to grow and expand content. Some new topics that you'll soon see on the site include information regarding tick borne illnesses, use of epi pens, use of insect repleents in children, and information regarding black box warning on medications for children.

KidsMeds also launched a twitter account (www.twitter.com/KidsMeds). This new resource for parents allows parents and practitioners to follow the happenings on KidsMeds. It also provides information from a variety of health information sources, such as the FDA, CDC. It is multidisciplinary in nature, and brings together content from pharmacists, nurses, physicians and other health care providers. Follow KidsMeds on twitter!

The Committee plans to promote KidsMeds to other health care and parent organizations and parent publications throughout the year.

The Advocacy Committee continues to provide position statements and reviews on behalf of PPAG. This past July, the Committee released a position regarding the use of antidepressants in children. The Committee is currently working on positions regarding Heparin use in pediatric patients, as well as, medications for the obese patient.

If you are interested in joining the Advocacy Committee, please contact Kristin Klein at kriklein@umich.edu or Tara Smith at tsmith@shhpens.org.

7-Jan-10 9:00 AM

Accepting 2010 FPPAG Applications

Matthew Helms — Wed, 06 Jan 2010 20:30:00 GMT

Application Deadline: June 1, 2010

PPAG is currently accepting applications from individuals who qualify for Fellowship in the Pediatric Pharmacy Advocacy Group.

In 2008, the Board of Directors approved the Fellowship in Pediatric Pharmacy Advocacy Group Recognition Program. This program is designed to recognize excellence in pediatric pharmacy practice and to publically promote those pharmacists who have distinguished themselves.

The general criteria for FPPAG recognition is as follows:

Candidate must demonstrate sustained practice excellence and professionalism in pediatric pharmacy practice for 10 years or greater.
Candidate shall have contributed to the total body of knowledge in pediatric pharmacy practice.
Candidate must be involved in and committed to educating practitioners in pediatric pharmacy practice and/or pharmacotherapy.
Candidate must demonstrate active involvement and leadership in professional activities, especially the Pediatric Pharmacy Advocacy Group.

To learn more about the criteria for recognition and the application procedures, please go to:

http://www.ppag.org/fppag/.

The application Deadline is June 1, 2010.

6-Jan-10 2:30 PM

Quality Assurance Specialist Pharmacist (Dosage Range Checking)

Thu, 11 Mar 2010 06:00:00 GMT

Title: Quality Assurance Specialist Pharmacist (Dosage Range Checking) Description: Quality Assurance Specialist Pharmacist (Dosage Range Checking) Lexi-Comp, Inc. is a leading provider of medical information and clinical content for the healthcare industry. Our mission is to provide unbiased and current point-of-care information used to improve patient outcomes. We offer an outstanding compensation package, a family-oriented, congenial working environment, and the opportunity to contribute to a growing company. Who we are We are passionate about our core values. We are highly ethical and honest. We think strategically and have the big picture in mind when we make decisions. We sweat the details. We are innovative, and expect our associates to bring new ideas to the table. We have a strong work ethic and work hard, and it shows in our results. We enjoy our work, its purpose, and the time we spend with all members of the company during professional and social activities. We consider...

Pharmacy Director

Mon, 08 Mar 2010 06:00:00 GMT

Title: Pharmacy Director Description: Rady Children’s Hospital San Diego. California 92123 The successful candidate will be responsible for the performance of all aspects of Pharmacy Services: planning, management of personnel, financial performance, distribution of medication, clinical services, procurement, storage, inventory control, compounding, quality assurance, and education. Required Experience: Minimum Qualifications: Completion of a minimum of a five year course at an accredited school of pharmacy, recognized by the State of California Board of Pharmacy, leading to a Bachelor of Pharmacy degree or an equivalent degree Current California licensure as a Registered Pharmacist in California in good standing Minimum of five years experience in a hospital pharmacy with two of those years in a pediatric setting Two years of supervisory experience Thorough knowledge of applicable federal, state, health and other regulatory laws, ethics and standards pertaining to hospital...

Pediatric and Staff Pharmacists

Fri, 05 Mar 2010 06:00:00 GMT

Title: Pediatric and Staff Pharmacists Description: Pediatric & Staff Pharmacists Make Banner Health an active ingredient in your pharmaceutical career. Cardon Children’s Medical Center is a new 200 bed hospital located on the campus of Banner Desert Medical Center in metro Phoenix Arizona. The campus has a total of 700 licensed beds. CCMC includes a 24 bed PICU, 24 bed Pediatric Hematology/Oncology unit, 72 General Pediatric patient beds, Pediatric outpatient treatment center and an 80 bed Level Three NICU. The pharmacy department provides progressive clinical services to our NICU, PICU, Peds/ONC and general pediatric populations. Future plans include further expansion of decentralized services to increase pharmacist interaction on the patient care team. The pharmacy department provides flexible schedule and professional growth opportunities. Available opportunities include: Pediatric Staff Pharmacists and Pediatric Clinical Specialist. Responsibilities/Duties...

Pharmacy Clinical Specialist Pediatrics

Mon, 01 Mar 2010 06:00:00 GMT

Title: Pharmacy Clinical Specialist Pediatrics Description: Lee Memorial Health System - Healthpark Medical Center In Beautiful Ft. Myers Florida in Southwest Florida near the Gulf of Mexico We are seeking a ......... Pediatric Pharmacy Clinical Specialist Represents the Pharmacy Department in a consultative and active role as the clinically oriented Pharmacist responsible for rational medication therapy in the pediatric patient population for The Children's Hospital of Southwest Florida and throughout Lee Memorial Health system. Serves as the pharmacy representative on system-wide committees requiring pediatric pharmacy expertise, interdisciplinary patient care teams, and the pharmacy leadership team. The Pediatric Pharmacy Clinical Specialist also serves as a pharmacy student and resident preceptor and supports the operations of the pharmacy as needed. The Children's Hospital of Southwest Florida is a part of HealthPark Medical Center and is comprised of 100 beds for...

Medication Dosing in Overweight and Obese Children

Wed, 17 Mar 2010 20:58:47 GMT

AUTHORS: Peter N. Johnson, Pharm.D., BCPS; Jamie L. Miller, Pharm.D., BCPS; Elizabeth A. Boucher, Pharm.D., BCPS .; Lisa Lubsch, Pharm.D.; Jennifer E. Girotto, Pharm.D., BCPS; Kimberly A. Pesaturo, Pharm.D., BCPS; Bernie Lee, Pharm.D.on behalf of the PPAG Advocacy Committee ACKNOWLEDGEMENTS: Seema Kumar, M.D., PdE BACKGROUND: The prevalence of overweight and obese American children has increased dramatically over the last three decades. Approximately 31.9 percent of children ages 2-19 years in 2003-2006 were considered overweight.1 The prevalence rates were highest among African-American females (39.2%) and Mexican-American males (40.8%).1 However, no significant differences have been noted in the prevalence between males and females. Pediatric patients are classified as overweight or obese according to their BMI percentile, or their BMI in relation to other children of the same age and gender. Reference standards for BMI percentile have been established for children 2-20...

Statement on Heparin Safety and Shortages

Wed, 17 Mar 2010 18:39:58 GMT

Authors: Kathy Pham, Pharm.D, BCPS on behalf of the PPAG Advocacy Committee BACKGROUND Heparin is an anticoagulant that has been used for a variety of indications, from thromboembolic prophylaxis and treatment to central venous access management. It is supplied in multiple concentrations for therapeutic and prophylactic use (1000 units/mL or higher) as well as in more dilute concentrations (100 units/mL or less) for heparin-lock flush solutions. Incidents with this medication at institutions across the country have brought safety concerns with heparin use to national attention. Safe use and monitoring of anticoagulants in particular is also highlighted by JCAHO’s National Patient Safety Goal (NPSG) 3E to “reduce the likelihood of patient harm associated with the use of anticoagulation therapy.” DESCRIPTION OF ISSUE Over the past 2 years, heparin overdoses have been widely publicized. In September 2006, three premature infants died after receiving an...

Practice Statements and Guidelines

Wed, 17 Mar 2010 18:32:49 GMT

The need for authoritative guidance in pediatric pharmacy practice has grown with changes in health care and with shifting influences from regulatory, accrediting, risk-management, financing, and other bodies. The PPAG Advocacy Committee develops official professional position statements for this purpose. PPAG offers therapeutic position statements that respond to specific therapeutic issues. These statements are thorough, evidence-based recommendations of drug use. PPAG also offers position statements on public policy issues that are directed to health care professionals, public officials, and the general public. PPAG position statements provide guidance and direction to PPAG members, pharmacy practitioners, and other audiences who affect pharmacy practice. Their use by members and other practitioners is strictly voluntary, and their content should be assessed and adapted to meet the needs of specific practice settings. Below is a list of our guidelines and position statements: ...

Statement on Standardized Drug Concentrations

Wed, 17 Mar 2010 18:14:36 GMT

BACKGROUND The Rule-of-Six has been used in pediatric emergency medicine for many years. Recently it has been under much scrutiny due to the variable concentrations that result when making the calculation to mix critical medication drips. The rule, or formula, multiplies a patient’s weight (in kilograms) by 6 to determine the dose of a medication (in milligrams) to be added to an appropriate diluent for a total volume of 100milliliters. The rate in ml/hr is equivalent to the dose in mcg/kg/min (i.e. 1 ml/hr equals 1 mcg/kg/min). Therefore, for each patient, there would be a different concentration infused, although the rate/dose would be the same. In addition, drastic changes in a patient’s weight would require compounding a new drip. In 2003 the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) revealed a list of 7 National Patient Safety Goals in an effort to make healthcare systems safer. Of these goals, it was stated that organizations should...

Neonatal Pharmacy Resident/Fellow Research Grant

Mon, 01 Mar 2010 20:26:12 GMT

Supported by Lundbeck, Inc. Application Deadline: September 15 each year. Pediatric Pharmacy Advocacy Group is an international, nonprofit, professional association representing the interests of pediatric pharmacists and their patients. We are dedicated to improving medication therapy in children. Our sole purpose is to promote safe and effective medication use in children through communication, education, and research. Purpose The Neonatal Pharmacy Resident/Fellow Research Grant supports research in neonatal medication use conducted by pharmacy residents (e.g., PGY-1, PGY-2 pediatric pharmacy resident) and fellows. The primary purpose of the research award is to improve safe and effective use of medications in neonates. Research projects can comprise a wide range of medication-use topics, including but not limited to: technology, safety, and/or pharmacotherapy. A secondary goal of the program is to develop and strengthen the skills of pharmacy residents and fellows by...

Online CE Programs

Fri, 26 Feb 2010 20:48:20 GMT

Pediatric Age-Based Competencies For more information about Aged-based Competency Series, please click here. Group purchasing opportunities are available. TITLE HRS. ACPE # PRICE Physiologic and Pharmacokinetic Differences in Children, Fluids and Electrolytes and Dehydration in Children 2.5 0180-0000-08-002-H04-P MEM: $10.00 NonMEM: $30.00 Respiratory Syncytial Virus: Diagnosis, Treatment and Prevention 1 0180-0000-09-001-H01-P MEM: $5.00 NonMEM: $15.00 Bronchopulmonary Dysplasia: Diagnosis, Prevention, and Treatment 1 0180-0000-09-002-H01-P MEM: $5.00 NonMEM: $15.00 Management of Asthma Exacerbations 1 0180-0000-09-003-H01-P MEM: $5.00 NonMEM: $15.00 DKA & HHS 1 0180-0000-09-100-H01-P MEM: $5.00 NonMEM: $15.00 Management of Diabetes Type 1 1 0180-0000-09-102-H01-P MEM: $5.00 NonMEM: $15.00 Pumps, Pens, and other Devices 1 0180-0000-09-103-H01-P MEM: $5.00 NonMEM: $15.00 Management of Diabetes, Type...

Age-based Competencies for Pediatric Pharmacists

Fri, 26 Feb 2010 20:45:46 GMT

Competency in pediatric medication therapy is an essential goal of the Pediatric Pharmacy Advocacy Group. Both the exigencies of patient care and Joint Commission on Accreditation of Healthcare Organizations (JCAHO) require assessment of this competency. PPAG offers a one-stop shop for your Aged-based Competency education and assessment needs. We offer audio/visual lectures and supporting material. These programs are accredited by the Accredidation Council of Pharmacy Education (ACPE). To receive credit for this program, you must complete and pass a post-test. Upon successful completion of the post-test, a certificate of credit will be automatically generated by the system for you to print. Certificates are stored in the system and will be accessible later. Please note: PPAG offers special group rates for our online Continuing Education Programs. Please go to: www.ppag.org/CEgrouprate for more information. CURRENT OFFERINGS Introductory Modules (combined 3 hour...

Membership FAQs

Tue, 23 Feb 2010 16:45:08 GMT

NOTE: All links provided below open a new browser window, this will allow you to read the intructions as you go step by step. Q) How long is a membership? Membership dues are good for one (1) year. You must renew your membership every year. Q) How much does membership cost? Membership is tiered. Individual and Associate Member Fee: $190.00 Resident/Fellow/Techninican fee: $60.00 Student Fee: $40.00 Q) Does membership include subscription to the Journal? Yes Q) I've moved. How can I let PPAG know my new address? You can update your contact info right here on the PPAG website! All you need is your login and password to enter user directories. Click the link provided, it will ask you for your login info before directing you [here]. Once you are on the directories search page, do a search for your name, then hit the submit button. Once you can view your record, hit the edit icon on the right side of your name (it will give you a detailed view of your...

Current Issue Cover

Tue, 16 Feb 2010 22:41:01 GMT

Volume 14 Number 4: Oct-Dec 2009 Editorial Use of Ototoxic Medications in Neonates—The Need for Follow-Up Hearing Test Tsz-Yin So, PharmD Brief Review Article Pediatric Fluid and Electrolyte Therapy Rachel S. Meyers, PharmD Review Article Women and Epilepsy Sunila E. O’Connor, MD and Mary L. Zupanc, MD Clinical Investigations Retrospective Analysis of the Initiation of Antibiotic Therapy In Severe Sepsis In Pediatric Patients Joseph M. LaRochelle, PharmD, Jill A. Morgan, PharmD, and Kristine A. Parbuoni, PharmD Improving Pediatric Outcomes through Intravenous and Oral Medication Standardization Mark W. MacKay, BSPharm, Jared Cash, PharmD, Fred Farr, PhD, Marc Holley BSPharm, Kevin Jones, BSPharm, and Sabrina Boehme, PharmD Click here for CURRENT ISSUE

Current Issue

Tue, 16 Feb 2010 22:17:06 GMT

Next Issue

Volume 15 Number 1 (Jan-Mar 2010) expected in March 2010

Acthar Gel (repository corticotrophin injection) Survey

noemail@ppag.org — Mon, 26 Feb 2007 17:00:00 GMT

Objectives:

This is a survey for pharmacies that order Acthar Gel (repository corticotrophin injection). The product is currently indicated for the treatment of acute exacerbations of multiple sclerosis and other conditions, and it is used off-label for treatment of infantile spasms. The maker of Acthar Gel, Questcor, filed a supplemental new drug application for the infantile spasms indication in August 2006. The company is now trying to understand how much of Acthar Gel usage is for multiple sclerosis and how much is for infantile spasms.

PPAG has received a small grant to conduct this survey.

Release Date: 26-Feb-07 11:00 AM
Expiration Date: 10-Apr-07 4:00 PM

if you use Acthar Gel, please fill out the survey to the best of your ability. Please coordinate within your institution so we do not receive duplicate information. We are not asking for facility name or participant information (involuntarily) in order to ensure confidentiality.

Medication Administration in Schools

noemail@ppag.org — Wed, 12 Jul 2006 19:00:00 GMT

Objectives:

We are looking to identify challenges and or cases within local school system or daycare settings.

For example: "Johnny’s" school doesn’t have a nurse, the school refuses to allow any medication administration, and so a parent goes to school everyday to administer!

The results of this survey will be presented at the 15th Annual Meeting during the Advocacy Workshop.

Release Date: 12-Jul-06 2:00 PM
Expiration Date: 10-Sep-06 2:00 PM
Please read and respond to the following questions.

What are your thoughts about PediNet?

noemail@ppag.org — Tue, 08 Nov 2005 15:00:00 GMT

Objectives: The Membership Services Committee values your opinion about the services PPAG provides its members. This survey was created to get your feedback about our PediNet Member Forums.

Release Date: 8-Nov-05 9:00 AM
Expiration Date: 14-Apr-06 9:00 AM
Please answer the questions provided. There are only 8 questions to answer. It should not take that long to complete.

2006-07 Educational Needs Assessment

noemail@ppag.org — Thu, 06 Oct 2005 02:00:00 GMT

Objectives: To better understand the continuing educational needs of our members.

Release Date: 5-Oct-05 9:00 PM
Expiration Date: 3-Jan-06 9:00 PM

Please offer comments in the text boxes provided.

Antifungal Survey for Stem Cell Transplantation/ Hematology-Oncology

noemail@ppag.org — Thu, 30 Jun 2005 21:00:00 GMT

Objectives:

To evaluate the use of antifungal agents in the pediatric hematology-oncology (H/O) and 

stem cell transplant (SCT) population and to assess differences in practice among various 

institutions.

Release Date: 30-Jun-05 4:00 PM
Expiration Date: 30-Mar-06 4:00 PM
Please participate in the following survey. Any PPAG member or affiliate can take the survey. Please coordinate your response within your institution to avoid duplicity.

To climb steep hills, requires slow pace at first.

Tue, 21 Jun 2005 23:24:19 GMT

"To climb steep hills, requires slow pace at first."

William Shakespeare, Henry VIII

Hot Topics in Pediatric ID, Critical Care, and Nutrition

2009-09-27T13:00:00Z

Instructor: Jeff Cies, PharmD and Betsy Walter, PharmD

This program is a two hour Audio presentation synced with PowerPoint slides. The program contains three sections. To begin this program, please click the start icon below. You can follow along by downloading the handout below. To download the PDF documents for each section, please click the go button below. After completion of the program, you may take the post-test to receive credit.

Community-Acquired MRSA in Pediatric Patients

2009-09-26T13:00:00Z

Instructor: Kristin Klein, PharmD

This program is a one hour Audio presentation synced with PowerPoint slides. To begin this program, please click the start icon below. You can follow along by downloading the handout below. To download the PDF document, please click the go button below. After completion of the program, you may take the post-test to receive credit.

Medication Use During ECMO and Continuous Renal Replacement Therapy

2009-09-26T13:00:00Z

Instructor: Brenda Dodson

This program is a one hour Audio presentation synced with PowerPoint slides. To begin this program, please click the start icon below. You can follow along by downloading the handout below. To download the PDF document, please click the go button below. After completion of the program, you may take the post-test to receive credit.

Management of Pediatric Chemical Casualties: Are We Prepared

2009-09-25T13:00:00Z

Instructor: Elora Hilmas

This program is a one hour Audio presentation synced with PowerPoint slides. To begin this program, please click the start icon below. You can follow along by downloading the handout below. To download the PDF document, please click the go button below. After completion of the program, you may take the post-test to receive credit.

Adolescents, Sexuality, and The Pediatric Pharmacist

2009-09-25T13:00:00Z

Instructor: Veenod Chulani

This program is a one hour Audio presentation synced with PowerPoint slides. To begin this program, please click the start icon below. You can follow along by downloading the handout below. To download the PDF document, please click the go button below. After completion of the program, you may take the post-test to receive credit.

Core Competency Series: Pumps, Pens, and other Devices

2009-09-24T18:00:00Z

Instructor: Thomas Parker

This program is a one hour Audio presentation synced with PowerPoint slides. To begin this program, please click the start icon below. You can follow along by downloading the handout below. To download the PDF document, please click the go button below. After completion of the program, you may take the post-test to receive credit.

Core Competency Series: Management of Diabetes Type 1

2009-09-24T18:00:00Z

Instructor: Michelle Condren

This program is a one hour Audio presentation synced with PowerPoint slides. To begin this program, please click the start icon below. You can follow along by downloading the handout below. To download the PDF document, please click the go button below. After completion of the program, you may take the post-test to receive credit.

Core Competency Series: Management of Diabetes, Type II

2009-09-24T18:00:00Z

Instructor: Allison Blackmer

This program is a one hour Audio presentation synced with PowerPoint slides. To begin this program, please click the start icon below. You can follow along by downloading the handout below. To download the PDF document, please click the go button below. After completion of the program, you may take the post-test to receive credit.

Core Competency Series: DKA & HHS

2009-09-24T18:00:00Z

Instructor: Mark Haase

This program is a one hour Audio presentation synced with PowerPoint slides. To begin this program, please click the start icon below. You can follow along by downloading the handout below. To download the PDF document, please click the go button below. After completion of the program, you may take the post-test to receive credit.

Core Competency Series: Bronchopulmonary Dysplasia: Diagnosis, Prevention, and Treatment

2009-03-25T13:00:00Z

Instructor: Sherry Luedtke, PharmD

This program is a one hour audio recording. To begin this program, please click the start icon below. You can follow along by downloading the handout below. To download the PDF document, please click the go button below. After completion of the program, you may take the post-test to receive credit.